← Open Payments lookup

BELINDA COWART: Open Payments

NPI 1619317120 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,034 in 180 payments from 25 companies in 2025. Trend: 2023 $2,538 · 2024 $4,092 · 2025 $4,034

Food & beverage: $3,904Education: $130
CompanyPaymentsAmount
GENZYME CORPORATION12$432
AstraZeneca Pharmaceuticals LP19$409
GlaxoSmithKline, LLC.21$319
United Therapeutics Corporation14$317
Regeneron Healthcare Solutions, Inc.11$315
Boehringer Ingelheim Pharmaceuticals, Inc.12$309
Insmed, Inc.10$230
Grifols USA, LLC10$226
Verona Pharma, Inc.12$198
Viatris Specialty LLC7$167

Products named: DUPIXENT, Tyvaso, TRELEGY ELLIPTA, Prolastin-C Liquid, Arikayce, Ohtuvayre, YUPELRI, Hillrom - Vest System Model 105 Home Care.

Industry payments across LA — which companies pay providers there.